47 related articles for article (PubMed ID: 1918889)
1. The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.
Kulkarni H; Marconi VC; He W; Landrum ML; Okulicz JF; Delmar J; Kazandjian D; Castiblanco J; Ahuja SS; Wright EJ; Weiss RA; Clark RA; Dolan MJ; Ahuja SK
Blood; 2009 Sep; 114(13):2783-92. PubMed ID: 19620399
[TBL] [Abstract][Full Text] [Related]
2. Zidovudine-induced neutropenia: are we too cautious?
Shaunak S; Bartlett JA
Lancet; 1989 Jul; 2(8654):91-2. PubMed ID: 2567882
[TBL] [Abstract][Full Text] [Related]
3. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
[TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor use is associated with decreased bacteremia and increased survival in neutropenic HIV-infected patients.
Keiser P; Rademacher S; Smith JW; Skiest D; Vadde V
Am J Med; 1998 Jan; 104(1):48-55. PubMed ID: 9528719
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of neutropenia in patients with human immunodeficiency virus infection.
Farber BF; Lesser M; Kaplan MH; Woltmann J; Napolitano B; Armellino D
Infect Control Hosp Epidemiol; 1991 Jul; 12(7):429-34. PubMed ID: 1918889
[TBL] [Abstract][Full Text] [Related]
8. Absence of neutropenia in African patients with AIDS and associated pyomyositis.
Ansaloni L; Acaye GL
East Afr Med J; 1994 Nov; 71(11):736-8. PubMed ID: 7859659
[TBL] [Abstract][Full Text] [Related]
9. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
Coyle TE
Med Clin North Am; 1997 Mar; 81(2):449-70. PubMed ID: 9093237
[TBL] [Abstract][Full Text] [Related]
10. [The acquired immunodeficiency syndrome (AIDS) in childhood].
Terragna A; Ferrazin A; Gotta C; Wenda-Ciravegna B
Medicina (Firenze); 1990; 10(3):256-62. PubMed ID: 1964193
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with Filgrastim in AIDS.
Kuritzkes DR
J Hematother Stem Cell Res; 1999; 8 Suppl 1():S17-9. PubMed ID: 10596031
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
Hewitt RG; Morse GD
Pharmacotherapy; 1992; 12(6):455-61. PubMed ID: 1492010
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
